论文部分内容阅读
目的：观察青光眼眼压调节器植入治疗难治性青光眼的远期临床效果。方法：对接受眼压调节器植入治疗的１３例１５只眼进行了回顾性总结。结果：在术后平均１４．７个月的随访中，仍保留眼压调节器者８只眼，治疗前眼压平均为４．３２±０．７６ｋＰａ，治疗后随访期间眼压为３．０２±０．７６ｋＰａ（ｔ＝４．４６５，Ｐ＝０．００１），摘除眼压调节器者７只眼，治疗前眼压平均为４．４５±０．８８ｋＰａ，治疗后随访期间眼压为３．０９±０．８０ｋＰａ（ｔ＝２．８８２，Ｐ＝０．０１４）。结论：青光眼眼压调节器植入是治疗难治性青光眼的方法之一。
Objective: To observe the long-term clinical effect of glaucoma intraocular pressure regulator implantation refractory glaucoma. Methods: Thirteen patients (15 eyes) undergoing intraocular pressure (IOP) device implantation were retrospectively reviewed. Results: In the follow-up of 14.7 months after operation, 8 eyes with intraocular pressure regulators remained, with an average of 4.32 ± 0.76 kPa before treatment and 3.02 after follow-up ± 0.76kPa (t = 4.465, P = 0.001). The intraocular pressure was 7 eyes after removal of intraocular pressure (IOP), the mean IOP before treatment was 4.45 ± 0.88kPa. The intraocular pressure .09 ± 0.80 kPa (t = 2.882, P = 0.014). Conclusion: Glaucoma intraocular pressure regulator implantation is one of the methods to treat refractory glaucoma.